Helicobacter pylori-induced indoleamine 2,3-dioxygenase activity in vivo is regulated by TGFB1 and CTLA4 polymorphisms

Molecular Immunology

Volumn 44, Issue 5, 2007, Pages 1011-1014

  Raitala, Annika ^a   Karjalainen, Jussi ^a   Oja, Simo S ^a,b   Kosunen, Timo U ^c   Hurme, Mikko ^a,b  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

CTLA4; Helicobacter pylori; IDO; TGFB1

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DIOXYGENASE; IMMUNOGLOBULIN G; INDOLEAMINE; KYNURENINE; TRANSFORMING GROWTH FACTOR BETA1; TRYPTOPHAN;

ADULT; AGED; ALLELE; ANTIBODY DETECTION; ARTICLE; BACTERIAL INFECTION; BLOOD ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENOTYPE; HELICOBACTER PYLORI; HETEROZYGOTE DETECTION; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; METABOLITE; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEROLOGY; SERUM; SUPPRESSOR CELL;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; FEMALE; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; KYNURENINE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSFORMING GROWTH FACTOR BETA1; TRYPTOPHAN;

HELICOBACTER PYLORI;

EID: 33748761147     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.03.006     Document Type: Article

References (19)

1. Ernst P.B., and Gold B.D. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu. Rev. Microbiol. 54 (2000) 615-640
2. Fallarino F., Grohmann U., Hwang K.W., Orabona C., Vacca C., Bianchi R., Belladonna M.L., Fioretti M.C., Alegre M.L., and Puccetti P. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4 (2003) 1206-1212
3. Go M.F. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 16 Suppl. 1 (2002) 3-15
4. Grainger D.J., Heathcote K., Chiano M., Snieder H., Kemp P.R., Metcalfe J.C., Carter N.D., and Spector T.D. Genetic control of the circulating concentration of transforming growth factor type β1. Hum. Mol. Genet. 8 (1999) 93-97
5. Karjalainen J., Hulkkonen J., Pessi T., Huhtala H., Nieminen M.M., Aromaa A., Klaukka T., and Hurme M. The IL1A genotype associates with atopy in nonasthmatic adults. J. Allergy Clin. Immunol. 110 (2002) 429-434
6. Kristiansen O.P., Larsen Z.M., and Pociot F. CTLA-4 in autoimmune diseases - a general susceptibility gene to autoimmunity?. Genes Immun. 1 (2000) 170-184
7. Laich A., Neurauter G., Widner B., and Fuchs D. More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clin. Chem. 48 (2002) 579-581
8. Ligers A., Teleshova N., Masterman T., Huang W.-X., and Hillert J. CTLA-4 gene expression in influenced by promoter and exon 1 polymorphisms. Genes Immun. 2 (2001) 145-152
9. +high regulatory T cells in Helicobacter pylori-infected patients. Infect. Immun. 73 (2005) 523-531
10. R cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197 (2003) 111-119
11. McGuirk P., and Mills K.H. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol. 23 (2002) 450-455
12. Mellor A.L., and Munn D.H. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?. Immunol. Today 10 (1999) 469-473
13. Mellor A.L., and Munn D.H. Ido expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4 (2004) 762-774
14. Mellor A.L., and Munn D.H. Tryptophan catabolism and regulation of adaptive immunity. J. Immunol. 170 (2003) 5809-5813
15. + suppressor T cells regulate pathogen induced inflammation and disease. FEMS Immunol. Med. Microbiol. 44 (2004) 121-127
16. Raitala A., Karjalainen J., Oja S.S., Kosunen T.U., and Hurme M. Indoleamine 2,3-dioxygenase (IDO) activity is lower in atopic than in non-atopic individuals and is enhanced by environmental factors protecting from atopy. Mol. Immunol. 43 (2006) 1054-1056
17. 1 promoter polymorphism C-509T is associated with asthma. Am. J. Respir. Crit. Care Med. 169 (2004) 214-219
18. Thompson C., and Powrie F. Regulatory T cells. Curr. Opin. Pharmacol. 4 (2004) 408-414
19. Uyttenhove C., Pilotte L., Théate I., Stroobant V., Colau D., Parmentier N., Boon T., and Van den Eynde B.J. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat. Med. 9 (2003) 1269-1274